NASDAQ:XAIR Beyond Air (XAIR) Stock Forecast, Price & News $2.11 -0.02 (-0.94%) (As of 12:18 PM ET) Add Compare Share Share Today's Range$2.06▼$2.1650-Day Range$2.13▼$3.6652-Week Range$2.06▼$8.06Volume127,354 shsAverage Volume402,806 shsMarket Capitalization$66.91 millionP/E RatioN/ADividend YieldN/APrice Target$12.25 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Beyond Air MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside475.1% Upside$12.25 Price TargetShort InterestBearish9.65% of Shares Sold ShortDividend StrengthN/ASustainability-0.91Upright™ Environmental ScoreNews Sentiment-0.27Based on 3 Articles This WeekInsider TradingAcquiring Shares$915,579 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($1.88) to ($1.69) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.97 out of 5 starsMedical Sector586th out of 975 stocksSurgical & Medical Instruments Industry65th out of 100 stocks 3.5 Analyst's Opinion Consensus RatingBeyond Air has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $12.25, Beyond Air has a forecasted upside of 475.1% from its current price of $2.13.Amount of Analyst CoverageBeyond Air has only been the subject of 2 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted9.65% of the outstanding shares of Beyond Air have been sold short.Short Interest Ratio / Days to CoverBeyond Air has a short interest ratio ("days to cover") of 6.7.Change versus previous monthShort interest in Beyond Air has recently increased by 9.68%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldBeyond Air does not currently pay a dividend.Dividend GrowthBeyond Air does not have a long track record of dividend growth. Previous Next 3.5 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreBeyond Air has received a 41.63% net impact score from Upright. Beyond Air seems to create the most significant positive value in categories "Jobs", "Physical diseases", and "Creating knowledge". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Medical ventilators", "Clinical research services for the respiratory system", and "Preclinical research services for physical health" products. See details.Environmental SustainabilityThe Environmental Impact score for Beyond Air is -0.91. Previous Next 1.0 News and Social Media Coverage News SentimentBeyond Air has a news sentiment score of -0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Beyond Air this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for XAIR on MarketBeat in the last 30 days. This is a decrease of -94% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Beyond Air to their MarketBeat watchlist in the last 30 days. This is a decrease of -83% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Beyond Air insiders have bought more of their company's stock than they have sold. Specifically, they have bought $915,579.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders15.58% of the stock of Beyond Air is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 30.60% of the stock of Beyond Air is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Beyond Air are expected to grow in the coming year, from ($1.88) to ($1.69) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Beyond Air is -1.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Beyond Air is -1.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBeyond Air has a P/B Ratio of 1.52. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Beyond Air (NASDAQ:XAIR) StockBeyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.Read More XAIR Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart XAIR Stock News HeadlinesOctober 2, 2023 | finance.yahoo.comBeyond Air® To Participate in the Roth MKM 2023 Healthcare Opportunities ConferenceSeptember 27, 2023 | finance.yahoo.comBeyond Cancer™ to Present Initial Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2023 SITC Annual MeetingOctober 3, 2023 | Edge On The Street (Ad)Is Gold Really Boring?Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. September 18, 2023 | finance.yahoo.comBeyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum DisorderSeptember 15, 2023 | finance.yahoo.comBeyond Air Insiders Placed Bullish Bets Worth US$2.3mSeptember 7, 2023 | finance.yahoo.comBeyond Air® and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific RegionSeptember 6, 2023 | finance.yahoo.comBeyond Air® To Participate in the 2023 Cantor Global Healthcare ConferenceAugust 24, 2023 | fool.comBeyond Air (NASDAQ: XAIR)October 3, 2023 | Edge On The Street (Ad)Is Gold Really Boring?Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. August 23, 2023 | benzinga.comDirector of Beyond Air Purchased $243K In StockAugust 11, 2023 | finance.yahoo.comBeyond Air® Reports Financial Results for First Quarter of Fiscal Year 2024August 11, 2023 | finance.yahoo.comBeyond Air® Reports Financial Results for First Quarter of Fiscal Year 2024August 8, 2023 | finance.yahoo.comBeyond Air® Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder (ASD)August 1, 2023 | finance.yahoo.comBeyond Air® To Participate in BTIG’s 2023 Virtual Biotechnology ConferenceJuly 29, 2023 | msn.comPiper Sandler Initiates Coverage of Beyond Air (XAIR) with Overweight RecommendationJuly 28, 2023 | msn.comBeyond Air ends selloff as Piper Sandler initiates at OverweightJuly 24, 2023 | finance.yahoo.comBeyond Air® Schedules First Fiscal Quarter 2024 Financial Results Conference Call and WebcastJuly 22, 2023 | msn.comTruist Securities Maintains Beyond Air (XAIR) Buy RecommendationJuly 6, 2023 | msn.comBeyond Air (XAIR) Price Target Decreased by 7.78% to 16.93June 22, 2023 | msn.comRecap: Beyond Air Q4 EarningsJune 22, 2023 | msn.comBeyond Air, Inc. (XAIR) Reports Q4 Loss, Lags Revenue EstimatesJune 22, 2023 | finance.yahoo.comBeyond Air® Reports Financial Results for Fourth Quarter and Fiscal Year-End 2023June 15, 2023 | finance.yahoo.comBeyond Air® Licenses Commercial Rights to Selective Neuronal Nitric Oxide Synthase (nNOS) Inhibitors for the Treatment of Autism Spectrum Disorder from Hebrew University of JerusalemJune 15, 2023 | finance.yahoo.comBeyond Air® Secures up to $40 Million Debt FinancingJune 15, 2023 | msn.comBeyond Air nears two-month high as BTIG starts at BuyJune 15, 2023 | msn.comBTIG Initiates Coverage of Beyond Air (XAIR) with Buy RecommendationJune 11, 2023 | finance.yahoo.comIs Beyond Air (NASDAQ:XAIR) In A Good Position To Invest In Growth?See More Headlines Receive XAIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Beyond Air and its competitors with MarketBeat's FREE daily newsletter. Email Address XAIR Company Calendar Last Earnings8/10/2023Today10/03/2023Next Earnings (Estimated)11/14/2023Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:XAIR CUSIPN/A CIK1641631 Webwww.beyondair.net Phone(516) 665-8200FaxN/AEmployees98Year FoundedN/APrice Target and Rating Average Stock Price Forecast$12.25 High Stock Price Forecast$15.00 Low Stock Price Forecast$10.00 Forecasted Upside/Downside+475.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($1.95) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-55,820,000.00 Net MarginsN/A Pretax Margin-106,444.07% Return on Equity-117.80% Return on Assets-79.22% Debt Debt-to-Equity Ratio0.35 Current Ratio5.27 Quick Ratio5.16 Sales & Book Value Annual Sales$870,000.00 Price / Sales77.63 Cash FlowN/A Price / Cash FlowN/A Book Value$1.40 per share Price / Book1.52Miscellaneous Outstanding Shares31,710,000Free Float26,770,000Market Cap$67.54 million OptionableNot Optionable Beta-0.28 The Best High-Yield Dividend Stocks for 2023Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Steven Adam Lisi (Age 52)CEO & Chairman Comp: $650kMr. Amir Avniel (Age 49)Pres, Chief Bus. Officer & Director Comp: $400kMr. Michael A. Gaul (Age 68)Chief Operating Officer Comp: $350kMr. Douglas Quinton Larson (Age 52)CFO, Principal Financial Officer & Principal Accounting Officer Edward BargerHead of Investor RelationsMs. Rebecca Van DorenHead of SalesMs. Kori-Ann TaylorHead of MarketingDr. Andrew R. Colin M.D.Sr. Medical Director Global Clinical Leadership & Member of Scientific Advisory BoardMr. Duncan FatkinChief Commercial OfficerDr. Jeff Myers M.D. (Age 58)Ph.D., Chief Medical Officer More ExecutivesKey CompetitorsCytosorbentsNASDAQ:CTSOMonogram OrthopaedicsNASDAQ:MGRMHealth Sciences Acquisitions Co. 2NASDAQ:HSAQInspireMDNYSE:NSPRCarmell TherapeuticsNASDAQ:CTCXView All CompetitorsInsiders & InstitutionsRobert CareyBought 250,000 shares on 8/28/2023Total: $672,500.00 ($2.69/share)Robert CareyBought 75,050 shares on 8/21/2023Total: $207,138.00 ($2.76/share)Osaic Holdings Inc.Sold 17,221 shares on 8/21/2023Ownership: 0.393%California State Teachers Retirement SystemBought 8,527 shares on 8/21/2023Ownership: 0.027%Robert CareyBought 13,614 shares on 8/18/2023Total: $35,940.96 ($2.64/share)View All Insider TransactionsView All Institutional Transactions XAIR Stock - Frequently Asked Questions Should I buy or sell Beyond Air stock right now? 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Beyond Air in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" XAIR shares. View XAIR analyst ratings or view top-rated stocks. What is Beyond Air's stock price forecast for 2023? 3 brokerages have issued twelve-month price objectives for Beyond Air's shares. Their XAIR share price forecasts range from $10.00 to $15.00. On average, they predict the company's share price to reach $12.25 in the next twelve months. This suggests a possible upside of 475.1% from the stock's current price. View analysts price targets for XAIR or view top-rated stocks among Wall Street analysts. How have XAIR shares performed in 2023? Beyond Air's stock was trading at $6.49 at the start of the year. Since then, XAIR stock has decreased by 67.2% and is now trading at $2.13. View the best growth stocks for 2023 here. When is Beyond Air's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023. View our XAIR earnings forecast. How were Beyond Air's earnings last quarter? Beyond Air, Inc. (NASDAQ:XAIR) posted its quarterly earnings results on Thursday, August, 10th. The company reported ($0.45) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.46) by $0.01. The firm earned $0.06 million during the quarter, compared to analysts' expectations of $0.20 million. What other stocks do shareholders of Beyond Air own? Based on aggregate information from My MarketBeat watchlists, some companies that other Beyond Air investors own include OPKO Health (OPK), NVIDIA (NVDA), Pfizer (PFE), Axsome Therapeutics (AXSM), BioCryst Pharmaceuticals (BCRX), Enphase Energy (ENPH), General Motors (GM), Livongo Health (LVGO), Main Street Capital (MAIN) and Ollie's Bargain Outlet (OLLI). What is Beyond Air's stock symbol? Beyond Air trades on the NASDAQ under the ticker symbol "XAIR." How do I buy shares of Beyond Air? Shares of XAIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Beyond Air's stock price today? One share of XAIR stock can currently be purchased for approximately $2.13. How much money does Beyond Air make? Beyond Air (NASDAQ:XAIR) has a market capitalization of $67.54 million and generates $870,000.00 in revenue each year. The company earns $-55,820,000.00 in net income (profit) each year or ($1.95) on an earnings per share basis. How can I contact Beyond Air? Beyond Air's mailing address is 825 EAST GATE BOULEVARD SUITE 320, GARDEN CITY NY, 11530. The official website for the company is www.beyondair.net. The company can be reached via phone at (516) 665-8200. This page (NASDAQ:XAIR) was last updated on 10/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beyond Air, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.